Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W S Fletcher

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Surgery, Gynecology & Obstetrics|December 1, 1988
Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumorsE A Woltering, E J Mozell, T M O'Dorisio, et al.
Cancer|April 1, 1975
Yoshi 864 (NSC 102627) 1-propanol, 3, 3'-iminodi-dimethanesulfonate (ester) hydrochloride: a phase 1 studyS J Altman, W S Fletcher, N C Andrews, et al.
Plastic and Reconstructive Surgery|April 1, 1989
Effectiveness of prophylactic mastectomy in the prevention of breast tumors in C3H miceH Nelson, S H Miller, D Buck, et al.
American Journal of Surgery|July 13, 2001
Usefulness of preoperative lymphoscintigraphy for the identification of sentinel lymph nodes in melanomaK T Morris, J S Stevens, R F Pommier, et al.
Medical and Pediatric Oncology|January 1, 1980
Cis-platinum therapy of previously treated head and neck cancer: the Southwest Oncology Group's two-dose-per-month outpatient regimenF J Panettiere, D Lehane, W S Fletcher, et al.
Journal of Surgical Oncology|January 1, 1975
A clinical trial of CCNU (1-(2 chloroethyl)-3-cyclohexyl-1-nitrosourea) (NSC 79037) in advanced ovarian carcinomaT M Sasaki, D B McConnell, H S Moseley, et al.
American Journal of Clinical Oncology|October 1, 1988
Evaluation of cis-platinum and DTIC combination chemotherapy in disseminated melanoma. A Southwest Oncology Group StudyW S Fletcher, S Green, J R Fletcher, et al.
Cancer Treatment Reports|June 1, 1985
Comparison of methotrexate and cisplatin for patients with advanced squamous cell carcinoma of the head and neck region: a Southwest Oncology Group StudyW E Grose, D E Lehane, D O Dixon, et al.
The Yale Journal of Biology and Medicine|November 24, 1998
The current status of somatostatin receptors in malignant melanomaW S Fletcher, S S Lum, R W Nance, et al.
Journal of Surgical Oncology|January 1, 1981
Hormone receptors in male breast carcinomaS J Ruff, J E Bauer, E J Keenan, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Surgery, Gynecology & Obstetrics|December 1, 1988
Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumorsE A Woltering, E J Mozell, T M O'Dorisio, et al.
Cancer|April 1, 1975
Yoshi 864 (NSC 102627) 1-propanol, 3, 3'-iminodi-dimethanesulfonate (ester) hydrochloride: a phase 1 studyS J Altman, W S Fletcher, N C Andrews, et al.
Plastic and Reconstructive Surgery|April 1, 1989
Effectiveness of prophylactic mastectomy in the prevention of breast tumors in C3H miceH Nelson, S H Miller, D Buck, et al.
American Journal of Surgery|July 13, 2001
Usefulness of preoperative lymphoscintigraphy for the identification of sentinel lymph nodes in melanomaK T Morris, J S Stevens, R F Pommier, et al.
Medical and Pediatric Oncology|January 1, 1980
Cis-platinum therapy of previously treated head and neck cancer: the Southwest Oncology Group's two-dose-per-month outpatient regimenF J Panettiere, D Lehane, W S Fletcher, et al.
Journal of Surgical Oncology|January 1, 1975
A clinical trial of CCNU (1-(2 chloroethyl)-3-cyclohexyl-1-nitrosourea) (NSC 79037) in advanced ovarian carcinomaT M Sasaki, D B McConnell, H S Moseley, et al.
American Journal of Clinical Oncology|October 1, 1988
Evaluation of cis-platinum and DTIC combination chemotherapy in disseminated melanoma. A Southwest Oncology Group StudyW S Fletcher, S Green, J R Fletcher, et al.
Cancer Treatment Reports|June 1, 1985
Comparison of methotrexate and cisplatin for patients with advanced squamous cell carcinoma of the head and neck region: a Southwest Oncology Group StudyW E Grose, D E Lehane, D O Dixon, et al.
The Yale Journal of Biology and Medicine|November 24, 1998
The current status of somatostatin receptors in malignant melanomaW S Fletcher, S S Lum, R W Nance, et al.
Journal of Surgical Oncology|January 1, 1981
Hormone receptors in male breast carcinomaS J Ruff, J E Bauer, E J Keenan, et al.
Pageof 11